PATENT CLAIM ANALYSIS

Application Number: 15755481
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-09
Patent Classification: ["514", "04400A"]

Abstract:
The present invention relates to novel isolated nucleic acid molecules (novel miRNAs and novel miRNA precursor molecules) as well as vectors, host cells, primers, cDNA-transcripts, polynucleotides derived from said isolated nucleic acid molecules and their use in diagnosis and therapy. Furthermore the present invention relates to methods and kits for diagnosing a disease, such as Multiple Sclerosis (MS) or Alzheimer's Disease (AD) employing said novel isolated nucleic acid molecules (novel miRNAs molecules).

Claim (Index 17):
The kit of  claim 16 , wherein the one or more polynucleotides comprise\n (i) a primer for reverse transcribing the at least one isolated nucleic acid molecule into a cDNA-transcript, and (ii) a set of primer pairs for amplifying the cDNA-transcript.

Metadata:
- Claim Count in Document: 30.0
- Percentile: 88.0
- Lexical Diversity: 1.69231
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14383518', '14873385', '13376225', '14442439', '11747409']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8090896904414696
- 35 USC 102 Novelty (BERT): 0.5397858720664872
- Combined Prediction Score: 0.7821593086039714
- Mean Citation Score: 349.89538000000016
- Max Citation Score: 386.3022
- Similarity Product: 274.33674533085826

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test